comparemela.com

Latest Breaking News On - Benjamin winograd - Page 2 : comparemela.com

LAVA Therapeutics Highlights Encouraging Clinical Updates on Lead Program, LAVA-051, in Chronic Lymphocytic Leukemia and Multiple Myeloma Patients

16.06.2022 - Clinical update call featuring LAVA-051 investigator Dr. Arnon Kater and Company management summarized initial Phase 1/2a clinical trial data presented at 2022 ASCO and EHA meetingsUTRECHT, The Netherlands and PHILADELPHIA, June 16, 2022 (GLOBE . Seite 1

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.